C

CareDx
D

CDNA

12.300
USD
-0.54
(-4.17%)
مغلق
حجم التداول
36,490
الربح لكل سهم
-0
العائد الربحي
-
P/E
11
حجم السوق
684,870,753
أصول ذات صلة
ABT
ABT
-2.397
(-1.86%)
126.190 USD
BDX
BDX
-3.340
(-1.84%)
178.290 USD
DGX
DGX
-1.280
(-0.76%)
167.500 USD
HOLX
HOLX
1.835
(2.82%)
66.835 USD
IDXX
IDXX
-37.98
(-6.63%)
534.50 USD
ILMN
ILMN
-3.990
(-3.74%)
102.730 USD
PODD
PODD
-9.96
(-3.34%)
288.46 USD
TMO
TMO
-9.54
(-2.00%)
467.89 USD
المزيد
الأخبار المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.